Oral fondaparinux: use of lipid nanocapsules as nanocarriers and in vivo pharmacokinetic study

Oral anticoagulant therapy could be advanced using lipid-based nanoparticulate systems. This study examined lipid nanocapsules for their oral absorption potential as the first step in developing oral fondaparinux (Fp) novel carriers. Using phase inversion method and cationic surfactants such as hexa...

Descripción completa

Detalles Bibliográficos
Autores principales: Ramadan, Alyaa, Lagarce, Frederic, Tessier-Marteau, Anne, Thomas, Olivier, Legras, Pierre, Macchi, Laurent, Saulnier, Patrick, Benoit, Jean Pierre
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2011
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3230563/
https://www.ncbi.nlm.nih.gov/pubmed/22162653
http://dx.doi.org/10.2147/IJN.S25791

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3230563/
https://www.ncbi.nlm.nih.gov/pubmed/22162653
http://dx.doi.org/10.2147/IJN.S25791

Ejemplares similares